European shares were holding lower come midday after the head of drug company Moderna said existing Covid vaccines may struggle to combat the Omicron variant of the SARS-CoV-2 virus.
"Friday's price action was likely a signal for at least a week of this kind of volatility, as markets scramble to price in the...
